Vectorite Biomedical Inc.

NT$11.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4170Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (10.36%)
Div yield —
ROE 26.13%
Biotechnology
Beta (5Y) 0.50
PE TTM 4.095
TSR TTM (21.99%)
Mkt cap NT$481.5M
ROIC (6.59%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$13
15.98%
(59.58%)
Hold 10|7|4|0|9
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.14
0.15
0.15
0.14
6.12%
12.65%
12.03%
4.70%
RevenueNT$M
38.06
37.62
39.31
38.89
7.88%
5.10%
9.66%
6.40%
Peers (US$14.28M)
Cap (US$)
PE
14.53M
112.3x
Capital
TTM
5Y
10Y
Leveragex
0.992
(0.062)
(0.060)
EBIT/Intx
0.212
0.474
0.472
Own earn%
126.89
56.67
61.58
Sh yield%
10.77
30.29
29.96
Owners
Insiders/Inst%
12.41
34.86
Short interest%
3.30
SBC / revenue%
5.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
15–21
$1 testx
0.0
Incr. ROIC%
0